Covid-19 Treatment
The Latest
-
U.S. To Buy $5 Billion Worth Of Pfizer's Paxlovid COVID-19 Treatment
The White House is reportedly planning to purchase 10 million doses of Pfizer's Paxlovid COVID-19 treatment, at an estimated cost of $5 billion. 
The White House is reportedly planning to purchase 10 million doses of Pfizer's Paxlovid COVID-19 treatment, at an estimated cost of $5 billion. -
Generic Antidepressant Repurposed As COVID-19 Treatment Shows Promise: Study
The fluvoxamine pill would cost $4 for a course of COVID-19 treatment. 
The fluvoxamine pill would cost $4 for a course of COVID-19 treatment. -
Llama Antibodies As COVID Treatment? Study Reveals 'Significant Potential' Of Unique Therapy
The team behind the new research is now seeking funds for potential human trials. 
The team behind the new research is now seeking funds for potential human trials. -
Israeli Medical Gas Cures 30 Patients With COVID-19; Hailed As 'Huge Breakthrough'
A new cure for COVID-19 developed by Israelis is a drug delivered in gaseous form that cured all the patients that took it. 
A new cure for COVID-19 developed by Israelis is a drug delivered in gaseous form that cured all the patients that took it. -
Gilead Sciences’ Remdesivir Is First FDA-Approved COVID-19 Treatment
One expert says the drug shows “modest" benefits but isn’t “a remarkable improvement." 
One expert says the drug shows “modest" benefits but isn’t “a remarkable improvement." -
Coronavirus: The Latest About COVID-19 Recovery
News about patients recovering from COVID-19 continues to bring hope to those still in treatment, but concerns about after-effects still linger. 
News about patients recovering from COVID-19 continues to bring hope to those still in treatment, but concerns about after-effects still linger. -
Coronavirus: NIH Panel Says Further Studies Needed Before Convalescent Plasma Is Used
"There are currently no data from well-controlled, adequately powered randomized clinical trials that demonstrate the efficacy and safety" of this treatment, NIH says. 
"There are currently no data from well-controlled, adequately powered randomized clinical trials that demonstrate the efficacy and safety" of this treatment, NIH says. -
Coronavirus Treatment: Experts Clash With FDA On Convalescent Plasma Use
There is still no sure treatment or cure for the novel coronavirus but some governments have authorized the use of several potential treatments. There is still no sure treatment or cure for the novel coronavirus but some governments have authorized the use of several potential treatments. -
Synairgen Drug Shows Promising Results In COVID-19 Trial
Patients were two to three times more likely to recover to the point where everyday activities were not compromised by their illness, Synairgen claims. 
Patients were two to three times more likely to recover to the point where everyday activities were not compromised by their illness, Synairgen claims. -
NIH Suspends Clinical Trials For Hydroxychloroquine Due To Lack Of Efficacy
The NIH stated that made the decision to halt clinical trials after it had found no real evidence of hydroxychloroquine's efficacy in treating coronavirus patients. 
The NIH stated that made the decision to halt clinical trials after it had found no real evidence of hydroxychloroquine's efficacy in treating coronavirus patients.
